Skip to main content
. Author manuscript; available in PMC: 2015 Sep 5.
Published in final edited form as: Am J Drug Alcohol Abuse. 2015 Sep;41(5):425–432. doi: 10.3109/00952990.2015.1049492

Table 2.

Repeated-measures ANOVA of smoking and neutral approach tendencies/biases at baseline and three-month follow up as a function of treatment condition (treatment vs. sham), site (USA vs. NL), and baseline smoking bias (approach vs. avoidance)

F p η 2
Between Subject Factors
Treatment Condition (treatment vs. sham) 0.03 0.86 0.01
Site (USA vs. NL) 12.13 0.002 0.32
Baseline Smoking Bias (approach vs. avoidance) 10.42 0.003 0.29
Within Subject Factors
Smoke Bias Score 1.42 0.24 0.05
Smoke Bias × Site 2.86 0.10 0.10
Smoke Bias × Treatment Condition 0.45 0.51 0.02
Smoke Bias × Baseline Smoking Bias 7.22 0.01 0.22
Smoking Bias × Treatment Condition × Baseline Smoking Bias 0.00 0.99 0.00
Neutral Bias Score 3.10 0.09 0.11
Neutral Bias × Site 0.13 0.73 0.01
Neutral Bias × Treatment Condition 0.002 0.96 0.00
Neutral Bias × Baseline Smoking Bias 1.15 0.29 0.04
Neutral Bias × Treatment Condition × Baseline Smoking Bias 0.34 0.56 0.01

Note: The model controlled for age.